Menopause is defined by a single day, the twelve-month anniversary of your last period. Perimenopause is the years leading up to it, and for most people it is longer, messier, and more consequential than the transition itself. It can begin in the early forties, sometimes the late thirties, and can last four to ten years. During that window, ovarian hormone production becomes erratic before it winds down, and the effects reach far beyond the reproductive system.
Much of what people report during perimenopause, sleep disruption, mood volatility, brain fog, joint aches, changes in body composition, has historically been attributed to stress, aging, or nothing in particular. The North American Menopause Society (NAMS) and international bodies have spent the last several years pushing back on that framing.
The hormonal picture
Perimenopause is not a straight decline in estrogen. Estrogen often swings higher than baseline in early perimenopause before it drops, while progesterone falls more steadily as ovulatory cycles become less reliable. These fluctuations, rather than the eventual low levels, drive most of the classic symptoms.
Cycles get shorter, then longer, then skip entirely. Bleeding can become heavier or lighter. Ovulation still happens intermittently, which means pregnancy is still possible until menopause is confirmed.
What actually changes
The symptom list is long, and no one gets all of them, but the common ones include:
- Hot flashes and night sweats, collectively called vasomotor symptoms
- Sleep disruption independent of night sweats, often waking at 3 or 4 a.m.
- Mood changes, including new or worsening anxiety and depressive symptoms
- Brain fog, word-finding difficulty, and slower recall
- Joint pain and stiffness, sometimes called menopausal arthralgia
- Vaginal dryness, urinary urgency, and painful sex, grouped as genitourinary syndrome of menopause
- Changes in cardiovascular and metabolic risk that begin to accelerate in this window
The average duration of moderate to severe vasomotor symptoms is roughly seven to ten years, longer than most people are told to expect and long enough to justify active treatment rather than waiting it out.
The care gap
Most clinicians receive limited training in menopause. Surveys of U.S. residency programs have repeatedly shown that many graduates feel unprepared to manage it. Patients often describe cycling through specialists, gynecologist, cardiologist, psychiatrist, rheumatologist, each treating a symptom without connecting the pattern.
That gap has consequences. Untreated vasomotor symptoms are linked to worse sleep, worse mood, and possibly worse long-term cardiovascular outcomes. Untreated genitourinary symptoms progress rather than resolve. And the perimenopause window is a critical one for setting bone, cardiovascular, and cognitive trajectories that play out over decades.
What helps
Menopause hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and, when initiated in appropriate candidates within roughly ten years of menopause onset, has a favorable risk profile for most healthy people. It also protects bone and treats genitourinary symptoms. The 2022 NAMS position statement lays out who is and is not a good candidate.
Non-hormonal options include SSRIs and SNRIs (paroxetine and venlafaxine have the most evidence for hot flashes), gabapentin, and the newer neurokinin-3 receptor antagonists like fezolinetant, which target the brain circuitry that generates hot flashes.
Local vaginal estrogen treats genitourinary symptoms with minimal systemic absorption and is considered safe for most people, including many with a history of hormone-sensitive cancers after specialist consultation.
Behavioral and lifestyle measures still matter. Resistance training preserves muscle and bone. Adequate protein intake becomes more important. Cognitive behavioral therapy has good evidence for hot flashes and sleep. Alcohol is a common trigger for both flashes and disrupted sleep.
Advocating for yourself
If your clinician is unfamiliar with menopause management, the NAMS website maintains a directory of certified menopause practitioners. Track your cycles and symptoms, including sleep and mood, and ask specifically about hormone therapy candidacy rather than accepting a general it is not for you.
The bottom line
Perimenopause is a long, real, medically actionable phase, not a personality change. Treatment options are broader than they were a decade ago, and the window in which treatment is safest is finite. Naming what is happening is the first step to addressing it.